A citation-based method for searching scientific literature

William C Hahn, Joel S Bader, Theodore P Braun, Andrea Califano, Paul A Clemons, Brian J Druker, Andrew J Ewald, Haian Fu, Subhashini Jagu, Christopher J Kemp, William Kim, Calvin J Kuo, Michael McManus, Gordon B Mills, Xiulei Mo, Nidhi Sahni, Stuart L Schreiber, Jessica A Talamas, Pablo Tamayo, Jeffrey W Tyner, Bridget K Wagner, William A Weiss, Daniela S Gerhard. Cell 2021
Times Cited: 18







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
16


Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study.
Jason K Sicklick, Shumei Kato, Ryosuke Okamura, Maria Schwaederle, Michael E Hahn, Casey B Williams, Pradip De, Amy Krie, David E Piccioni, Vincent A Miller,[...]. Nat Med 2019
181
11

Deciphering molecular interactions by proximity labeling.
Wei Qin, Kelvin F Cho, Peter E Cavanagh, Alice Y Ting. Nat Methods 2021
19
11

High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.
Yi Zhu, Tobias Weiss, Qiushi Zhang, Rui Sun, Bo Wang, Xiao Yi, Zhicheng Wu, Huanhuan Gao, Xue Cai, Guan Ruan,[...]. Mol Oncol 2019
34
11

Proteomics. Tissue-based map of the human proteome.
Mathias Uhlén, Linn Fagerberg, Björn M Hallström, Cecilia Lindskog, Per Oksvold, Adil Mardinoglu, Åsa Sivertsson, Caroline Kampf, Evelina Sjöstedt, Anna Asplund,[...]. Science 2015
11

Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry.
Charlotte Giesen, Hao A O Wang, Denis Schapiro, Nevena Zivanovic, Andrea Jacobs, Bodo Hattendorf, Peter J Schüffler, Daniel Grolimund, Joachim M Buhmann, Simone Brandt,[...]. Nat Methods 2014
693
11

The Tumor Microenvironment Innately Modulates Cancer Progression.
Dominique C Hinshaw, Lalita A Shevde. Cancer Res 2019
335
11

Proteogenomic characterization of human colon and rectal cancer.
Bing Zhang, Jing Wang, Xiaojing Wang, Jing Zhu, Qi Liu, Zhiao Shi, Matthew C Chambers, Lisa J Zimmerman, Kent F Shaddox, Sangtae Kim,[...]. Nature 2014
799
11

Proteogenomics connects somatic mutations to signalling in breast cancer.
Philipp Mertins, D R Mani, Kelly V Ruggles, Michael A Gillette, Karl R Clauser, Pei Wang, Xianlong Wang, Jana W Qiao, Song Cao, Francesca Petralia,[...]. Nature 2016
787
11

Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
Kazuaki Suda, Hirofumi Nakaoka, Kosuke Yoshihara, Tatsuya Ishiguro, Ryo Tamura, Yutaro Mori, Kaoru Yamawaki, Sosuke Adachi, Tomoko Takahashi, Hiroaki Kase,[...]. Cell Rep 2018
135
5

Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium.
Brian C Willis, Emily A Sloan, Kristen A Atkins, Mark H Stoler, Anne M Mills. Mod Pathol 2017
31
5

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
Ji Yon Agnes Jang, Nozomu Yanaihara, Eric Pujade-Lauraine, Yoshiki Mikami, Katsutoshi Oda, Michael Bookman, Jonathan Ledermann, Muneaki Shimada, Takako Kiyokawa, Byoung Gie Kim,[...]. J Gynecol Oncol 2017
9
11

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.
Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos, Pamela McKay, Tycel Phillips, Sarit Assouline, Connie Lee Batlevi, Phillip Campbell, Vincent Ribrag, Gandhi Laurent Damaj,[...]. Lancet Oncol 2020
58
5

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Jianfeng Shen, Yang Peng, Leizhen Wei, Wei Zhang, Lin Yang, Li Lan, Prabodh Kapoor, Zhenlin Ju, Qianxing Mo, Ie-Ming Shih,[...]. Cancer Discov 2015
227
5

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.
Ronald L Chandler, Jeffrey S Damrauer, Jesse R Raab, Jonathan C Schisler, Matthew D Wilkerson, John P Didion, Joshua Starmer, Daniel Serber, Della Yee, Jessie Xiong,[...]. Nat Commun 2015
165
5

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Mary L Disis, Matthew H Taylor, Karen Kelly, J Thaddeus Beck, Michael Gordon, Kathleen M Moore, Manish R Patel, Jorge Chaves, Haeseong Park, Alain C Mita,[...]. JAMA Oncol 2019
151
5

Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma.
Takafumi Kuroda, Hideaki Ogiwara, Mariko Sasaki, Kazuaki Takahashi, Hiroshi Yoshida, Takako Kiyokawa, Kazuki Sudo, Kenji Tamura, Tomoyasu Kato, Aikou Okamoto,[...]. Gynecol Oncol 2019
15
6

Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary: Incidence and Morphologic Associations in 109 Cases.
Jennifer A Bennett, Vicente Morales-Oyarvide, Sharon Campbell, Teri A Longacre, Esther Oliva. Am J Surg Pathol 2016
26
5

Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Takahiro Oike, Hideaki Ogiwara, Takashi Nakano, Jun Yokota, Takashi Kohno. Jpn J Clin Oncol 2013
40
5

Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Christina M Nagle, Catherine M Olsen, Penelope M Webb, Susan J Jordan, David C Whiteman, Adèle C Green. Eur J Cancer 2008
59
5

Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
Martin Köbel, Steve E Kalloger, David G Huntsman, Jennifer L Santos, Kenneth D Swenerton, Jeffrey D Seidman, C Blake Gilks. Int J Gynecol Pathol 2010
227
5

Epigenetic inhibitors for the precision treatment of ARID1A-mutant ovarian cancers: what are the next steps?
Takeshi Fukumoto, Rugang Zhang, Benjamin G Bitler. Expert Rev Precis Med Drug Dev 2018
3
33

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.
U A Matulonis, R Shapira-Frommer, A D Santin, A S Lisyanskaya, S Pignata, I Vergote, F Raspagliesi, G S Sonke, M Birrer, D M Provencher,[...]. Ann Oncol 2019
187
5

Histone deacetylase 6 in cancer.
Ting Li, Chao Zhang, Shafat Hassan, Xinyue Liu, Fengju Song, Kexin Chen, Wei Zhang, Jilong Yang. J Hematol Oncol 2018
97
5

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
875
5

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
Hisham Abou-Taleb, Ken Yamaguchi, Noriomi Matsumura, Ryusuke Murakami, Hidekatsu Nakai, Koichiro Higasa, Yasuaki Amano, Kaoru Abiko, Yumiko Yoshioka, Junzo Hamanishi,[...]. Oncotarget 2016
16
6

Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Hiroko Machida, Koji Matsuo, Wataru Yamagami, Yasuhiko Ebina, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kanauchi, Satoru Nagase, Takayuki Enomoto, Mikio Mikami. Gynecol Oncol 2019
36
5

Tazemetostat: First Approval.
Sheridan M Hoy. Drugs 2020
58
5

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Cigall Kadoch, Diana C Hargreaves, Courtney Hodges, Laura Elias, Lena Ho, Jeff Ranish, Gerald R Crabtree. Nat Genet 2013
692
5

ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation.
Mike R Wilson, Jake J Reske, Jeanne Holladay, Subechhya Neupane, Julie Ngo, Nina Cuthrell, Marc Wegener, Mary Rhodes, Marie Adams, Rachael Sheridan,[...]. Cell Rep 2020
3
33

Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.
Kathy Qi Cai, Constance Albarracin, Daniel Rosen, Rocksheng Zhong, Wenxin Zheng, Rajyalakshmi Luthra, Russell Broaddus, Jinsong Liu. Hum Pathol 2004
96
5

Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers.
Mariko Sasaki, Fumiko Chiwaki, Takafumi Kuroda, Masayuki Komatsu, Keisuke Matsusaki, Takashi Kohno, Hiroki Sasaki, Hideaki Ogiwara. Biochem Biophys Res Commun 2020
6
16

Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
Nazar Mashtalir, Andrew R D'Avino, Brittany C Michel, Jie Luo, Joshua Pan, Jordan E Otto, Hayley J Zullow, Zachary M McKenzie, Rachel L Kubiak, Roodolph St Pierre,[...]. Cell 2018
185
5

Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.
Yusuke Shibuya, Hideki Tokunaga, Sakae Saito, Kazurou Shimokawa, Fumiki Katsuoka, Li Bin, Kaname Kojima, Masao Nagasaki, Masayuki Yamamoto, Nobuo Yaegashi,[...]. Genes Chromosomes Cancer 2018
48
5

Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma.
Shogo Shigeta, Goldie Y L Lui, Reid Shaw, Russell Moser, Kay E Gurley, Grace Durenberger, Rachele Rosati, Robert L Diaz, Tan A Ince, Elizabeth M Swisher,[...]. Mol Cancer Ther 2021
4
25

Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients.
Kiyoshi Yoshino, Takayuki Enomoto, Masami Fujita, Yutaka Ueda, Toshihiro Kimura, Eiji Kobayashi, Tateki Tsutsui, Tadashi Kimura. Int J Clin Oncol 2013
19
5

Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer.
Don S Dizon, Lars Damstrup, Neil J Finkler, Ulrik Lassen, Paul Celano, Ros Glasspool, Elizabeth Crowley, Henri S Lichenstein, Poul Knoblach, Richard T Penson. Int J Gynecol Cancer 2012
44
5

Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Susan J Jordan, Adèle C Green, David C Whiteman, Suzanne P Moore, Christopher J Bain, Dorota M Gertig, Penelope M Webb. Int J Cancer 2008
70
5

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.
Leora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, Somayyeh Fahiminiya, Nancy Hamel, Eva Tomiak, David Grynspan, Emmanouil Saloustros, Javad Nadaf, Barbara Rivera,[...]. Nat Genet 2014
258
5

Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression.
Shih-Yao Lin, Jen-Fan Hang, Yen-Yu Lin, Chiung-Ru Lai, Hsiang-Ling Ho, Teh-Ying Chou. Int J Gynecol Pathol 2021
1
100

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
Michael S Anglesio, Mark S Carey, Martin Köbel, Helen Mackay, David G Huntsman. Gynecol Oncol 2011
171
5

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.
Hideaki Ogiwara, Kazuaki Takahashi, Mariko Sasaki, Takafumi Kuroda, Hiroshi Yoshida, Reiko Watanabe, Ami Maruyama, Hideki Makinoshima, Fumiko Chiwaki, Hiroki Sasaki,[...]. Cancer Cell 2019
81
5

Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma.
Jennifer A Bennett, Nida Safdar, Jeremy P Segal, Ricardo R Lastra, Esther Oliva. Int J Gynecol Pathol 2021
1
100

ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Mike R Wilson, Jake J Reske, Jeanne Holladay, Genna E Wilber, Mary Rhodes, Julie Koeman, Marie Adams, Ben Johnson, Ren-Wei Su, Niraj R Joshi,[...]. Nat Commun 2019
42
5

Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Amilcar Barreta, Luís Otávio Sarian, Amanda Canato Ferracini, Larissa Bastos Eloy Costa, Priscila Gava Mazzola, Liliana de Angelo Andrade, Sophie Derchain. Hum Pathol 2019
7
14

Cancer-Associated Mutations in Endometriosis without Cancer.
Michael S Anglesio, Nickolas Papadopoulos, Ayse Ayhan, Tayyebeh M Nazeran, Michaël Noë, Hugo M Horlings, Amy Lum, Siân Jones, Janine Senz, Tamer Seckin,[...]. N Engl J Med 2017
257
5

Increased incidence of severe gastrointestinal events with first-line paclitaxel, carboplatin, and vorinostat chemotherapy for advanced-stage epithelial ovarian, primary peritoneal, and fallopian tube cancer.
Alberto A Mendivil, John P Micha, John V Brown, Mark A Rettenmaier, Lisa N Abaid, Katrina L Lopez, Bram H Goldstein. Int J Gynecol Cancer 2013
13
7

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.
Tuan Zea Tan, Jieru Ye, Chung Vin Yee, Diana Lim, Natalie Yan Li Ngoi, David Shao Peng Tan, Ruby Yun-Ju Huang. EBioMedicine 2019
17
5

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors.
Katrien Berns, Joseph J Caumanns, E Marielle Hijmans, Annemiek M C Gennissen, Tesa M Severson, Bastiaan Evers, G Bea A Wisman, Gert Jan Meersma, Cor Lieftink, Roderick L Beijersbergen,[...]. Oncogene 2018
39
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.